BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jun 21, 2026; 32(23): 118489
Published online Jun 21, 2026. doi: 10.3748/wjg.v32.i23.118489
Table 1 Baseline characteristics of patients, n (%)
CharacteristicsOverall cohort (unadjust)
PSM cohort
IPTW cohort
Laparoscopic (n = 83)
Open (n = 96)
P value
SMD
Laparoscopic (n = 74)
Open (n = 74)
P value
SMD
Laparoscopic (n = 70.35)
Open (n = 86.23)
P value
SMD
Age (year)59.0 (52.0, 65.0)58.5 (53.8, 64.0)0.8670.0458.0 (52.0, 64.8)58.0 (53.0, 64.0)0.8850.0359.00 (52.0, 65.0)58.00 (53.0, 64.0)0.933< 0.01
Sex0.5050.06-1.0000.01-
Female33 (39.8)44 (45.8)30 (40.5)31 (41.9)28.26 (40.2)36.70 (42.6)0.7560.05
Male50 (60.2)52 (54.2)44 (59.5)43 (58.1)42.08 (59.8)49.53 (57.4)
BMI (kg/m2)23.6 (22.7, 25.4)24.6 (23.2, 25.7)0.4240.1523.6 (22.5, 25.4)24.0 (22.4, 25.5)0.7750.0623.60 (22.6, 25.4)23.97 (22.6, 25.6)0.7180.07
ASA score0.3720.12-0.7990.04-
115 (18.1)18 (18.8)14 (18.9)15 (20.3)11.65 (16.6)5.15 (17.6)0.8930.07
241 (49.4)38 (39.6)38 (51.4)34 (45.9)34.09 (48.5)38.63 (44.8)--
327 (32.5)40 (41.7)22 (29.7)25 (33.8)24.61 (35.0)32.45 (37.6)--
Neoadjuvant chemotherapy1.0000.01-0.8380.03-
No69 (83.1)79 (82.3)60 (81.1)58 (78.4)57.90 (82.3)70.87 (82.2)0.984< 0.01
Yes14 (16.9)17 (17.7)14 (18.9)16 (21.6)12.45 (17.7)15.36 (17.8)--
cTNM stage0.2720.06-0.9290.01-0.7830.09
I26 (31.3)36 (37.5)26 (35.1)25 (33.8)22.95 (32.6)30.46 (35.3)
II31 (37.3)40 (41.7)31 (41.9)30 (40.5)27.33 (38.8)35.31 (41.0)
III26 (31.3)20 (20.8)17 (23.0)19 (25.7)20.07 (28.5)20.46 (23.7)


Write to the Help Desk